90 related articles for article (PubMed ID: 15902286)
1. Higher-grade transformation of follicular lymphoma -- a continuous enigma.
Lossos IS
Leukemia; 2005 Aug; 19(8):1331-3. PubMed ID: 15902286
[No Abstract] [Full Text] [Related]
2. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
3. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Davies AJ; Lee AM; Taylor C; Clear AJ; Goff LK; Iqbal S; Cuthbert-Heavens D; Calaminici M; Norton AJ; Lister TA; Fitzgibbon J
Leukemia; 2005 Aug; 19(8):1459-65. PubMed ID: 15902285
[TBL] [Abstract][Full Text] [Related]
4. Histological progression of follicular lymphoma associated with p53 mutation and rearrangement of the C-MYC gene.
Takimoto Y; Takafuta T; Imanaka F; Kuramoto A; Sasaki N; Nanba K
Hiroshima J Med Sci; 1996 Jun; 45(2):69-73. PubMed ID: 8810134
[TBL] [Abstract][Full Text] [Related]
5. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma.
Akasaka T; Lossos IS; Levy R
Blood; 2003 Aug; 102(4):1443-8. PubMed ID: 12738680
[TBL] [Abstract][Full Text] [Related]
6. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
[TBL] [Abstract][Full Text] [Related]
7. mdm-2 oncoprotein expression associated with deletion of the long arm of chromosome 12 in a case of mantle cell lymphoma with blastoid transformation [corrected].
Haidar JH; Neiman RS; Orazi A; Albitar M; McCarthy LJ; Heerema N
Mod Pathol; 1996 Apr; 9(4):355-9. PubMed ID: 8729971
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture.
Freedman DA; Levine AJ
Cancer Res; 1999 Jan; 59(1):1-7. PubMed ID: 9892174
[No Abstract] [Full Text] [Related]
9. Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma.
Wrench D; Waters R; Carlotti E; Iqbal S; Matthews J; Calaminici M; Gribben J; Lister TA; Fitzgibbon J
Haematologica; 2009 Jan; 94(1):148-50. PubMed ID: 19029147
[No Abstract] [Full Text] [Related]
10. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Bond GL; Hu W; Bond EE; Robins H; Lutzker SG; Arva NC; Bargonetti J; Bartel F; Taubert H; Wuerl P; Onel K; Yip L; Hwang SJ; Strong LC; Lozano G; Levine AJ
Cell; 2004 Nov; 119(5):591-602. PubMed ID: 15550242
[TBL] [Abstract][Full Text] [Related]
11. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK
Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788
[TBL] [Abstract][Full Text] [Related]
12. Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang Y; Xiong Y
Cell Growth Differ; 2001 Apr; 12(4):175-86. PubMed ID: 11331246
[TBL] [Abstract][Full Text] [Related]
13. Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.
Symmans WF; Katz RL; Ordoñez NG; Dalton H; Romaguera JE; Cabanillas F
Acta Cytol; 1995; 39(4):673-82. PubMed ID: 7631541
[TBL] [Abstract][Full Text] [Related]
14. Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.
Møller MB; Nielsen O; Pedersen NT
Mod Pathol; 1999 Nov; 12(11):1010-6. PubMed ID: 10574597
[TBL] [Abstract][Full Text] [Related]
15. Robust diagnosis of non-Hodgkin lymphoma phenotypes validated on gene expression data from different laboratories.
Bhanot G; Alexe G; Levine AJ; Stolovitzky G
Genome Inform; 2005; 16(1):233-44. PubMed ID: 16362926
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the ras genes is a rare genetic event in the histologic transformation of follicular lymphoma.
Clark HM; Yano T; Sander C; Jaffe ES; Raffeld M
Leukemia; 1996 May; 10(5):844-7. PubMed ID: 8656681
[TBL] [Abstract][Full Text] [Related]
17. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma.
Brynes RK; Wilson CS; Kim AB; McCourty A
Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063
[TBL] [Abstract][Full Text] [Related]
19. Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein.
Shiozawa E; Yamochi-Onizuka T; Yamochi T; Yamamoto Y; Naitoh H; Kawakami K; Nakamaki T; Tomoyasu S; Kushima M; Ota H
Pathol Res Pract; 2003; 199(5):293-302. PubMed ID: 12908519
[TBL] [Abstract][Full Text] [Related]
20. Gallium-67 uptake by cutaneous lesions in a patient with Burkitt-like non-Hodgkin's lymphoma.
Ruíz-Hernández G; Gutiérrez-García A; García-Conde J
Haematologica; 2000 Jul; 85(7):772. PubMed ID: 10897137
[No Abstract] [Full Text] [Related]
[Next] [New Search]
